StonvexLoading…
StonvexStonvexStonvexCore line items from FDMT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $3.05M | $85.21M | $119.00K | $29.00K |
Operating Income | $-73.62M | $-159.55M | $-174.26M | $-113.08M |
Net Income | $-68.76M | $-140.11M | $-159.51M | $-54.66M |
EPS (Diluted) | $-1.01 | $-2.42 | $-2.85 | $-1.84 |
Total Assets | $512.90M | $566.71M | $423.98M | $473.64M |
Total Liabilities | $61.07M | $61.05M | $55.00M | $52.75M |
Cash & Equivalents | $72.49M | $60.24M | $48.55M | $77.16M |
Free Cash Flow OCF − CapEx | Not available | $-109.62M | $-138.24M | $-91.83M |
Shares Outstanding | 52.27M | 57.61M | 46.77M | 46.70M |